Ticker Details
Pulse Biosciences, Inc. Pulse Biosciences Inc is a development stage medical device company using a novel and proprietary platform technology called Nano-Pulse Electro-Signaling or NPES for biomedical applications.
IPO Date:	May 18, 2016
Sector:	Healthcare
Industry:	Medical Instruments and Equipment
Market Cap:	$3.6B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.53 | 3.94%
Avg Daily Range (30 D):	$1.34 | 3.83%
Avg Daily Range (90 D):	$1.04 | 3.73%

Institutional Daily Volume
Avg Daily Volume:	.14M
Avg Daily Volume (30 D):	.34M
Avg Daily Volume (90 D):	.3M

Trade Size
Avg Trade Size (Sh.):	92
Avg Trade Size (Sh.) (30 D):	52
Avg Trade Size (Sh.) (90 D):	58

Institutional Trades
Total Institutional Trades:	262
Avg Institutional Trade:	$1.38M
Avg Institutional Trade (30 D):	$1.45M
Avg Institutional Trade (90 D):	$1.34M
Avg Institutional Trade Volume:	.07M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.4M
Avg Closing Trade (30 D):	$1.6M
Avg Closing Trade (90 D):	$1.25M
Avg Closing Volume:	74.15K

News

May 4, 2026 @ 10:27 PM Pulse Biosciences (PLSE) Q1 2025 Earnings Transcri... Source: Motley Fool Transcribing

Apr 1, 2024 @ 7:33 AM Oxford Industries, PVH And 3 Stocks To Watch Headi... Source: Avi Kapoor

Mar 11, 2024 @ 5:41 PM Why Mesoblast Shares Are Trading Higher By 13%? He... Source: Avi Kapoor

Jan 2, 2024 @ 4:47 PM Rivian Automotive Reports Weak Delivery Figures, J... Source: Avi Kapoor

Dec 19, 2023 @ 6:55 PM Tech Stocks Set New All-Time High, Small Caps On F... Source: Piero Cingari

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-1.18	$-.36	$-.27
Diluted EPS
Revenue	$1.19M	$.43M	$.4M
Gross Profit	$M	$.16M	$.03M
Net Income / Loss	$-80.06M	$-24.66M	$-18.58M
Operating Income / Loss	$-83.04M	$-25.27M	$-19.15M
Cost of Revenue	$1.18M	$.27M	$.37M
Net Cash Flow	$-4.73M	$33.3M	$-12.42M
PE Ratio